Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)
29.66
-0.68 (-2.24%)
Oct 29, 2026, 2:15 PM CST
SHE:300957 Revenue
Yunnan Botanee Bio-Technology Group Co.LTD had revenue of 1.05B CNY in the quarter ending September 30, 2026, a decrease of -4.28%. This brings the company's total for the last twelve months to 5.53B, up 6.74% year-over-year. In the year 2025, Yunnan Botanee Bio-Technology Group Co.LTD had annual revenue of 5.36B, down -6.58%. That makes Yunnan Botanee Bio-Technology Group Co.LTD the 8,506th largest company in the world by revenue and 1,311th in China.
Revenue (ttm)
5.53B
Revenue Growth
+6.74%
P/S Ratio
2.29
Revenue / Employee
1.55M
Employees
3,574
Market Cap
12.37B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHE:300957 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.36B | -377.23M | -6.58% |
| Dec 31, 2024 | 5.74B | 8.56M | 0.15% |
| Dec 31, 2023 | 5.73B | 713.43M | 14.23% |
| Jan 1, 2023 | 5.01B | 991.47M | 24.65% |
| Jan 1, 2022 | 4.02B | 1.39B | 52.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.